Steven Cohen Amarin Corp Plcuk Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $6.97 Million - $12.1 Million	500,000 New	500,000 $10.7 Million
Q3 2019 Nov 15, 2019	SELL	$13.89 - $23.16 $13.9 Million - $23.2 Million	-1,000,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $16.3 Million - $20.5 Million	1,000,000 New	1,000,000 $19.4 Million

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $298M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.